The purpose of the NSGO – Gynaecological Cancer Research Grant is to provide financial support to upcoming researchers within gynaecological oncology to establish innovative oncological, surgical, translational, and supportive care research projects and trials. Projects that facilitate collaboration among the Nordic countries and synergy between research partners will be prioritized.
The aim of the NSGO – Gynaecological Cancer Research Grant is to:
Strengthen clinical and preclinical collaborative research within gynaecological oncology
Support investigator-initiated trials with administrative support
Only preclinical and clinical research projects will be considered. There must be a focus on gynaecological oncology, and specifically on predisposing, predictive and/or prognostic factors and/or treatment strategies for ovarian, endometrial, cervical, or vulvar cancer or trophoblastic disease. Projects with full industry funding are not eligible.
The projects should unite researchers, preferentially from all Nordic countries. At a minimum, researchers from other Nordic countries must be invited to participate to solve challenges within the area of gynaecological oncology. This could be accomplished by sharing clinical data sets, biopsy samples, or infrastructure, or by other means. International scientific and clinical collaboration is encouraged.
The main applicant must be a NSGO member and anchored at a Nordic university hospital.
Co-applicant(s) must work within gynaecological oncology in one of the Nordic countries. They can be working at the same country as the main applicant.
Additional co-applicants can be anchored at other non-profit research institutions, universities, or hospitals within or beyond the Nordic region.
The amount of funding provided for each successful project will be determined on a case-by-case basis. The provided funding will not exceed €20,000 per applicant or per project.
Concept Development Form
Deadline is the 16th of February 2024.
Each successful main applicant will be obliged to deliver a presentation on the project’s progress at the next yearly NSGO meeting
The main applicant must first complete the Concept Development Form on the NSGO website, providing an introduction and brief overview of the proposed research project (including the aim and hypotheses). The NSGO-CTU will then discuss the proposed projects and select projects for further submission. The main applicants of the selected projects will be invited to submit a detailed proposal containing the project’s background, hypothesis, materials and methods, ethical aspects, publication plan, timeline, and budget (maximum 30,000 characters). Following the submission, the main applicant will be invited to present and discuss their proposed research project with the NSGO Grant Review Committee.
All applications must be submitted through the NSGO website (https://nsgo.org/nsgo-organisation/), which contains important information on the application process and deadlines.
NSGO Grant Review Committee
The NSGO Grant Review Committee is a Nordic peer review panel.
The principal task of the NSGO Grant Review Committee is to perform a professional peer review evaluation of applications for the NSGO – Gynaecological Cancer Research Grant.
The NSGO Grant Review Committee consists of seven active researchers at Nordic research institutions. The committee should be well-balanced in terms of the members’ research fields (e.g., translational research, databases, surgery, systemic treatment, radiotherapy, and patient-reported outcomes).
The NSGO Grant Review Committee has three predefined members: the current NSGO president and president-elect, and the past president of the NSGO. The other four members are appointed for two years by the NSGO Board. They should represent the four Nordic countries (Norway, Sweden, Finland, and Denmark), and each must be a trustworthy person with high academic competence within the field of gynaecology or oncology.